{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:22:01Z","timestamp":1790403721220,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,2,20]],"date-time":"2015-02-20T00:00:00Z","timestamp":1424390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s10067-015-2889-y","type":"journal-article","created":{"date-parts":[[2015,2,19]],"date-time":"2015-02-19T07:54:25Z","timestamp":1424332465000},"page":"1821-1824","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Anaphylaxis to anakinra in a pediatric patient with systemic juvenile idiopathic arthritis successfully treated with canakinumab: a case-based review"],"prefix":"10.1007","volume":"34","author":[{"given":"Cassyanne L.","family":"Aguiar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Barinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,20]]},"reference":[{"key":"2889_CR1","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390\u2013392","journal-title":"J Rheumatol"},{"key":"2889_CR2","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/art.38092","volume":"65","author":"S Ringold","year":"2013","unstructured":"Ringold S, Weiss PF, Beukelman T, DeWitt EM, Ilowite NT, Kimura Y et al (2013) 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis. Arthritis Rheum 65:2499\u20132512","journal-title":"Arthritis Rheum"},{"key":"2889_CR3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/art.30128","volume":"63","author":"PA Nigrovic","year":"2011","unstructured":"Nigrovic PA, Mannion M, Prince FH, Zeft A, Rabinovich CE, van Rossum MA et al (2011) Anakinra as first-line disease modifying therapy in systemic juvenile idiopathic arthritis. Arthritis Rheum 63:545\u2013555","journal-title":"Arthritis Rheum"},{"key":"2889_CR4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/RHU.0b013e318285f1e9","volume":"19","author":"CB Crayne","year":"2013","unstructured":"Crayne CB, Gerhold K, Cron RQ (2013) Anaphylaxis to etanercept in two children with juvenile idiopathic arthritis. J Clin Rheumatol 19:129\u2013131","journal-title":"J Clin Rheumatol"},{"key":"2889_CR5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2133.2005.06635.x","volume":"153","author":"AT Vila","year":"2005","unstructured":"Vila AT, Puig L, Fernandez-Figueras MT, Laiz AM, Vidal D, Alomar A (2005) Adverse cutaneous reactions to anakinra in patients with rheumatoid arthritis: clinicopathological study of five patients. Br J Dermatol 153:417\u2013423","journal-title":"Br J Dermatol"},{"key":"2889_CR6","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jaad.2007.11.004","volume":"59","author":"CG Regula","year":"2008","unstructured":"Regula CG, Hennessy J, Clarke LE, Adams DR, Ioffreda MD, Graber EM et al (2008) Interstitial granulomatous drug reaction to anakinra. J Am Acad Dermatol 59:S25\u2013S27","journal-title":"J Am Acad Dermatol"},{"key":"2889_CR7","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/ard.2008.093492","volume":"68","author":"S Vordenb\u00e4umen","year":"2009","unstructured":"Vordenb\u00e4umen S, Ostendorf B, Sander O, Richter J, Schneider M (2009) Continuation of anakinra despite the development of a pruritic rash in an otherwise refractory case of adult-onset Still\u2019s disease. Ann Rheum Dis 68:450\u2013451","journal-title":"Ann Rheum Dis"},{"key":"2889_CR8","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1345\/aph.1L573","volume":"43","author":"D Desai","year":"2009","unstructured":"Desai D, Goldbach-Mansky R, Milner JD, Rabin RL, Hull K, Pucino F et al (2009) Anaphylactic reaction to anakinra in a rheumatoid arthritis patient intolerant to multiple nonbiologic and biologic disease-modifying antirheumatic drugs. Ann Pharmacother 43:967\u2013972","journal-title":"Ann Pharmacother"},{"key":"2889_CR9","first-page":"S24","volume":"23","author":"J Anton","year":"2005","unstructured":"Anton J, Ros J, Ricard S, Giner MT, Plaza AM, Villaronga M et al (2005) Desensitization to anakinra in a systemic onset juvenile idiopathic arthritis patient [abstract]. Clin Exp Rheumatol 23:S24","journal-title":"Clin Exp Rheumatol"},{"key":"2889_CR10","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","volume":"367","author":"N Ruperto","year":"2012","unstructured":"Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat N, Horneff G et al (2012) Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. N Engl J Med 367:2396\u20132406","journal-title":"N Engl J Med"},{"key":"2889_CR11","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1002\/art.38042","volume":"65","author":"DJ Lovell","year":"2013","unstructured":"Lovell DJ, Giannini EH, Reiff AO, Kimura Y, Li S, Hashkes PJ et al (2013) Long-term safety and efficacy of rilonacept in patients with systemic juvenile idiopathic arthritis. Arthritis Rheum 65:2486\u20132496","journal-title":"Arthritis Rheum"},{"key":"2889_CR12","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","volume":"367","author":"F Benedetti De","year":"2012","unstructured":"De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I et al (2012) Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med 367:2385\u20132395","journal-title":"N Engl J Med"},{"issue":"Suppl 10","key":"2889_CR13","first-page":"1613","volume":"60","author":"RF Vollenhoven van","year":"2009","unstructured":"van Vollenhoven RF, Keystone EC, Furie R, Blesch A, Wang C, Curtis JR (2009) Gastrointestinal safety in patients with rheumatoid arthritis treated with tocilizumab: data from Roche clinical trials [abstract]. Arthritis Rheum 60(Suppl 10):1613","journal-title":"Arthritis Rheum"},{"key":"2889_CR14","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s11926-012-0314-y","volume":"15","author":"N Yeoh","year":"2013","unstructured":"Yeoh N, Burton JP, Suppiah P, Reid G, Stebbings S (2013) The role of the microbiome in rheumatic diseases. Curr Rheumatol Rep 15:314","journal-title":"Curr Rheumatol Rep"},{"key":"2889_CR15","doi-asserted-by":"crossref","first-page":"e01202","DOI":"10.7554\/eLife.01202","volume":"2","author":"JU Scher","year":"2013","unstructured":"Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, Bielski C et al (2013) Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2:e01202","journal-title":"Elife"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-2889-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-015-2889-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-2889-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:57:39Z","timestamp":1559120259000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-015-2889-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,20]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["2889"],"URL":"https:\/\/doi.org\/10.1007\/s10067-015-2889-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,20]]}}}